GlycoMimetics, Inc.
GLYC
GLYC: GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.
moreShow GLYC Financials
Recent trades of GLYC by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by GLYC's directors and management
Government lobbying spending instances
-
$10,000 Oct 20, 2011 Issue: Health Issues
-
$10,000 Jul 18, 2011 Issue: Health Issues
-
$10,000 Apr 18, 2011 Issue: Health Issues
-
$10,000 Jan 19, 2011 Issue: Health Issues
-
$10,000 Oct 19, 2010 Issue: Health Issues
-
$10,000 Jul 19, 2010 Issue: Health Issues
-
$10,000 Apr 16, 2010 Issue: Health Issues
-
$10,000 Jan 20, 2010 Issue: Health Issues
-
$10,000 Oct 19, 2009 Issue: Health Issues
New patents grants
-
Patent Title: Methods of mobilizing marrow infiltrating lymphocytes and uses thereof Aug. 01, 2023
-
Patent Title: Methods for treating acute myeloid leukemia and related conditions Jul. 25, 2023
-
Patent Title: Heterobifunctional inhibitors of e-selectin and galectin-3 Jan. 10, 2023
-
Patent Title: Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4 Sep. 06, 2022
-
Patent Title: E-selectin antagonist compounds, compositions, and methods of use May. 17, 2022
-
Patent Title: Methods for the treatment and/or prevention of cardiovascular disease by inhibition of e-selectin Apr. 05, 2022
-
Patent Title: Galactopyranosyl-cyclohexyl derivauves as e-selectin antagonists Dec. 14, 2021
-
Patent Title: Highly potent multimeric e-selectin antagonists Jul. 27, 2021
-
Patent Title: Glycomimetic inhibitors of pa-il and pa-iil lectins Jun. 29, 2021
-
Patent Title: E-selectin antagonist compounds, compositions, and methods of use Sep. 08, 2020
-
Patent Title: E-selectin antagonist compounds, compositions, and methods of use Jan. 07, 2020
-
Patent Title: Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors Dec. 31, 2019
-
Patent Title: Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells Jan. 16, 2018
-
Patent Title: E-selectin antagonist compounds, compositions, and methods of use Oct. 24, 2017
-
Patent Title: Pan-selectin inhibitor with enhanced pharmacokinetic activity Jan. 03, 2017
-
Patent Title: E-selectin antagonist compounds, compositions, and methods of use Aug. 18, 2015
-
Patent Title: E-selectin antagonists Dec. 30, 2014
-
Patent Title: Pan-selectin inhibitor with enhanced pharmacokinetic activity Nov. 25, 2014
-
Patent Title: Heterobifunctional pan-selectin inhibitors Feb. 25, 2014
-
Patent Title: Heterobifunctional pan-selectin inhibitors Jan. 21, 2014
-
Patent Title: Compounds and methods for inhibiting selectin-mediated function Sep. 10, 2013
-
Patent Title: Treatment of cancers of the blood using selected glycomimetic compounds Aug. 27, 2013
-
Patent Title: Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors Apr. 02, 2013
-
Patent Title: Compounds and methods for treatment of sickle cell or complications associated therewith Jan. 29, 2013
-
Patent Title: Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from Sep. 04, 2012
-
Patent Title: Compounds and methods for treatment of sickle cell disease or complications associated therewith Oct. 18, 2011
-
Patent Title: Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines Sep. 27, 2011
-
Patent Title: Heterobifunctional pan-selectin inhibitors Aug. 02, 2011
-
Patent Title: Glycomimetic replacements for hexoses and n-acetyl hexosamines Jun. 21, 2011
-
Patent Title: Compounds and methods for inhibiting selectin-mediated function Jun. 22, 2010
-
Patent Title: Heterobifunctional pan-selectin inhibitors Jun. 01, 2010
-
Patent Title: Detection and treatment of prostate cancer Jun. 01, 2010
Federal grants, loans, and purchases
Followers on GLYC's company Twitter account
Number of mentions of GLYC in WallStreetBets Daily Discussion
Recent insights relating to GLYC
Recent picks made for GLYC stock on CNBC
ETFs with the largest estimated holdings in GLYC
Flights by private jets registered to GLYC